1998 SCHEDULE 13G - REGENERON PHARMACEUT

Company

REGENERON PHARMACEUTICALS, INC.

Filed

February 11, 1999

Accession Number

0000354204-99-000597

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →